Ac-DEVD-CHO |
 |
| SYNONYMS | Caspase-3 Inhibitor (Aldehyde) Caspase-7 Inhibitor (Aldehyde) |
 |
 |
| PRODUCT LINE | Cell Death / Apoptosis / Autophagy |
 |
 |
| PRODUCT FAMILIES | Caspase Inhibitors |
 |
 |
 |
| Ordering Information |
 |
| Product Numbers | Format | Size | Unit Price | Quantity |  | | ALX-260-030-M001 |
|
1 mg | | | | | ALX-260-030-M005 |
|
5 mg | | | |  | |  |
|
 |
| Product Specification |
 |
|
| SEQUENCE: | Ac-Asp-Glu-Val-Asp-CHO |
 |
 |
| |
|
| FORMULA: | C20H30N4O11 |
 |
 |
| |
|
| MW: | 502.5 |
 |
 |
| |
|
| PEPTIDE CONTENT: | 70-90%. |
 |
 |
| |
|
| PURITY: | ≥95% (HPLC) |
 |
 |
| |
|
| FORMULATION: | Lyophilized. |
 |
 |
| |
|
| SOLUBILITY: | Soluble in distilled water or DMSO. |
 |
 |
| |
|
| RECONSTITUTION: | Add 0.2ml DMSO per 1mg peptide. Shake well until all the contents are dissolved. This furnishes a 10mM solution of this material. |
 |
 |
| |
|
| SHIPPING: | AMBIENT |
 |
 |
| |
|
| LONG TERM STORAGE: | -20°C |
 |
 |
| |
|
| USE/STABILITY: | Stock solutions should be divided into aliquots and stored at -20°C. Solutions are stable for at least 1 month when stored at -20°C in the dark and protected from moisture. |
 |
 |
| |
|
| HANDLING: | Keep cool and dry. Keep under nitrogen. |
 |
 |
|
 |
| Product Description |
Reversible inhibitor of caspase-3 and -7. |
|
 | | Product Specific Literature References | Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis: D.W. Nicholson, et al.; Nature 376, 37 (1995) Abstract Sequential activation of ICE-like and CPP32-like proteases during Fas- mediated apoptosis: M. Enari, et al.; Nature 380, 723 (1996) Abstract ICE/CED3-like proteases as therapeutic targets for the control of inappropriate apoptosis: D.W. Nicholson; Nature Biotechnol. 14, 297 (1996) Abstract CPP32/apopain is a key interleukin 1 beta converting enzyme-like protease involved in Fas-mediated apoptosis: J. Schlegel, et al.; J. Biol. Chem. 271, 1841 (1996) Full Text; http://www.jbc.org/cgi/reprint/271/4/1841.pdf A sequential two-step mechanism for the production of the mature p17:p12 form of caspase-3 in vitro: Z. Han, et al.; J. Biol. Chem. 272, 13432 (1997) Full Text; http://www.jbc.org/cgi/reprint/272/20/13432.pdf Inhibition of human caspases by peptide-based and macromolecular inhibitors: M. Garcia-Calvo, et al.; J. Biol. Chem. 273, 32608 (1998) Full Text; http://www.jbc.org/cgi/reprint/273/49/32608.pdf Inhibition of ubiquitin-proteasome pathway activates a caspase-3-like protease and induces Bcl-2 cleavage in human M-07e leukaemic cells: X.M. Zhang, et al.; Biochem. J. 340, 127 (1999) Full Text; http://www.biochemj.org/bj/340/0127/bj3400127.htm |
|
|
 |
|
| RELATED PRODUCT GROUPS |
|
 |
 |
 |